Farallon Capital Management LLC Repligen Corp Transaction History

Farallon Capital Management LLC

  • $19.9 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
BUY
$161.19 - $257.96 $14 Million - $22.4 Million
86,734 Added 63.66%
222,979 $41.9 Million
Q4 2021

Feb 14, 2022
BUY
$247.59 - $304.47 $11.2 Million - $13.8 Million
45,175 Added 49.6%
136,245 $36.1 Million
Q3 2021

Nov 15, 2021
BUY
$194.77 - $324.21 $17.7 Million - $29.5 Million
91,070 New
91,070 $26.3 Million

Others Institutions Holding RGEN

# of Institutions
487
Shares Held
54.4M
Call Options Held
341K
Put Options Held
235K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Farallon Capital Management LLC Portfolio

Follow Farallon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farallon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farallon Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email